Literature DB >> 10867665

Abdominal sonographic study of autosomal dominant polycystic kidney disease.

C Nicolau1, R Torra, L Bianchi, R Vilana, R Gilabert, A Darnell, C Brú.   

Abstract

PURPOSE: The purpose of this study was to determine whether kidney size in patients who have autosomal dominant polycystic kidney disease (ADPKD) is related to renal function, hypertension, or extrarenal manifestations of the disease and to sonographically evaluate the abdominal manifestations of ADPKD.
METHODS: Between 1994 and 1998, 400 individuals from 85 families with a history of ADPKD were examined. There were 213 persons with ADPKD and 187 unaffected family members; there were 182 males and 218 females, 1-82 years old (mean, 39.3 years). We obtained a complete medical history, performed a physical examination, measured the arterial blood pressure and serum creatinine levels, and performed abdominal sonography on each subject. The sonographic features that were studied were renal length and the presence and number of cysts on the kidneys, liver, and pancreas.
RESULTS: There was a relationship between kidney size and age (p < 0.05), kidney size and renal function (p < 0.001), and kidney size and hypertension (p < 0.001). The overall prevalence of hepatic cysts in patients with ADPKD was 67%, and the prevalence increased with age. The presence of hepatic cysts was related to the severity of renal disease. Females had more severe polycystic liver disease, and massive polycystic liver disease (ie, hepatomegaly with innumerable cysts) was seen only in females. The prevalence of pancreatic cysts in the 187 persons in whom the pancreas was well evaluated sonographically was 5%.
CONCLUSIONS: Kidney size in patients with ADPKD is related to renal function, hypertension, and extrarenal involvement and can be used to predict the outcome of the disease. Hepatic cysts are very common in patients with ADPKD and are related to age and renal function; pancreatic cysts are infrequent in these patients. Copyright 2000 John Wiley & Sons, Inc.

Entities:  

Mesh:

Year:  2000        PMID: 10867665     DOI: 10.1002/1097-0096(200007/08)28:6<277::aid-jcu2>3.0.co;2-l

Source DB:  PubMed          Journal:  J Clin Ultrasound        ISSN: 0091-2751            Impact factor:   0.910


  11 in total

Review 1.  Pathophysiology, epidemiology, classification and treatment options for polycystic liver diseases.

Authors:  Bassam Abu-Wasel; Caolan Walsh; Valerie Keough; Michele Molinari
Journal:  World J Gastroenterol       Date:  2013-09-21       Impact factor: 5.742

Review 2.  Evaluation and management of pain in autosomal dominant polycystic kidney disease.

Authors:  Marie C Hogan; Suzanne M Norby
Journal:  Adv Chronic Kidney Dis       Date:  2010-05       Impact factor: 3.620

Review 3.  Clinical manifestations of autosomal recessive polycystic kidney disease (ARPKD): kidney-related and non-kidney-related phenotypes.

Authors:  Rainer Büscher; Anja K Büscher; Stefanie Weber; Julia Mohr; Bianca Hegen; Udo Vester; Peter F Hoyer
Journal:  Pediatr Nephrol       Date:  2013-10-10       Impact factor: 3.714

Review 4.  Primary cilia in pancreatic development and disease.

Authors:  Sukanya Lodh; Elizabeth A O'Hare; Norann A Zaghloul
Journal:  Birth Defects Res C Embryo Today       Date:  2014-05-26

Review 5.  Translational research in ADPKD: lessons from animal models.

Authors:  Hester Happé; Dorien J M Peters
Journal:  Nat Rev Nephrol       Date:  2014-08-19       Impact factor: 28.314

6.  Boy with autosomal recessive polycystic kidney and autosomal dominant polycystic liver disease.

Authors:  Andrea Zingg-Schenk; Jürg Caduff; Silvia Azzarello-Burri; Carsten Bergmann; Joost P H Drenth; Thomas J Neuhaus
Journal:  Pediatr Nephrol       Date:  2012-03-14       Impact factor: 3.714

7.  PKHD1, the polycystic kidney and hepatic disease 1 gene, encodes a novel large protein containing multiple immunoglobulin-like plexin-transcription-factor domains and parallel beta-helix 1 repeats.

Authors:  Luiz F Onuchic; Laszlo Furu; Yasuyuki Nagasawa; Xiaoying Hou; Thomas Eggermann; Zhiyong Ren; Carsten Bergmann; Jan Senderek; Ernie Esquivel; Raoul Zeltner; Sabine Rudnik-Schöneborn; Michael Mrug; William Sweeney; Ellis D Avner; Klaus Zerres; Lisa M Guay-Woodford; Stefan Somlo; Gregory G Germino
Journal:  Am J Hum Genet       Date:  2002-03-15       Impact factor: 11.025

Review 8.  Polycystic Liver Disease: Pathophysiology, Diagnosis and Treatment.

Authors:  Luiz Fernando Norcia; Erika Mayumi Watanabe; Pedro Tadao Hamamoto Filho; Claudia Nishida Hasimoto; Leonardo Pelafsky; Walmar Kerche de Oliveira; Ligia Yukie Sassaki
Journal:  Hepat Med       Date:  2022-09-29

9.  Pancreatic Cysts in Autosomal Dominant Polycystic Kidney Disease: Prevalence and Association with PKD2 Gene Mutations.

Authors:  Jin Ah Kim; Jon D Blumenfeld; Shalini Chhabra; Silvina P Dutruel; Nanda Deepa Thimmappa; Warren O Bobb; Stephanie Donahue; Hanna E Rennert; Adrian Y Tan; Ashley E Giambrone; Martin R Prince
Journal:  Radiology       Date:  2016-04-05       Impact factor: 11.105

10.  Incremental health care resource utilization and expenditures associated with autosomal-dominant polycystic kidney disease.

Authors:  Neeraj N Iyer; Nicholas J Vendetti; Daniel I Levy; Jack Mardekian; Marko A Mychaskiw; Joseph Thomas
Journal:  Clinicoecon Outcomes Res       Date:  2018-10-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.